No Detail Found!

Comparative evaluation of Nigella sativa (Kalonji) and simvastatin for the treatment of hyperlipidemia and in the induction of hepatotoxicity.

Author(s)
Kirn-e-Muneera Department of Biochemistry and Molecular Biology, National University of Sciences and Technology, Rawalpindi, Pakistan
Asifa Majeed Department of Biochemistry and Molecular Biology, National University of Sciences and Technology, Rawalpindi, Pakistan
Abdul Khaliq Naveed Department of Biochemistry and Molecular Biology, National University of Sciences and Technology, Rawalpindi, Pakistan
Abstract
Hyperlipidemia is a major risk factor for incidence of coronary artery disease. Simvastatin is a synthetic lipid lowering drug and Nigella sativa seeds found helpful in controlling hyperlipidemia. The study performed to evaluate the efficacy of Nigella sativa in comparison to simvastatin to treat hyperlipidemia. Thirty Sprague Dawley rats fed on an ad libitum diet for 02 weeks, on cholesterol diet for 08 weeks. Then group II treated with simvastatin and group III with Nigella sativa for 06 weeks. Blood samples analyzed for serum cholesterol, serum triglycerides, HDL-C, LDL-C & serum ALT. The results evident that Nigella sativa (kalonji) and simvastatin showed significant improvement in the lipid profile of rats in respective groups after treatment. The p value Nigella sativa (kalonji) affect the lipid profile in the same way as of simvastatin. However, ALT levels significantly raised in group II treated with simvastatin compared to group III. Nigella sativa and simvastatin showed comparable effects in the treatment of hyperlipidemia. Nigella sativa showed protective role in terms of hepatic dysfunction and can be used as a cholesterol lowering agent.
Publication Details
Page(s) 493-498
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 28, Issue: 2, Year: 2015

Request the full text from PASTIC

0

Citations

0

Downloads

67

Views